Electrochemiluminescence (ECL) imaging, as an optical
technology,
has been developed at full tilt in the field of life science and nanomaterials.
However, the relatively low ECL intensity or the high co-reactant
concentration needed in the electrochemical reaction blocks its practical
application. Here, we developed an ECL imaging system based on the
rGO-TiO2–x
composite material,
where the co-reactant, reactive oxygen species (ROS), is generated
in situ under the synergetic effect of of ultrasound (US) and electric
irradiation. The rGO-TiO2–x
composites
facilitate the separation of electron (e–) and hole
(h+) pairs and inhibit recombination triggered by external
US irradiation due to the high electroconductivity of rGO and oxygen-deficient
structures of TiO2, thus significantly boosting ROS generation.
Furthermore, the increased defects on rGO accelerate the electron
transfer rate, improving the electrocatalytic performance of the composite
and forming more ROS. This high ultrasonic–electric synergistic
efficacy is demonstrated through the enhancement of photon emission.
Compared with the luminescence intensity triggered by US irradiation
and electric field, an enhancement of ∼20-fold and 10-fold
of the US combined with electric field-triggered emission is observed
from this composite. Under the optimized conditions, using dopamine
(DA) as a model target, the sensitivity of the US combined ECL strategy
for detection of DA is two orders of magnitude higher than that of
the ECL method. The successful detection of DA at low concentrations
makes us believe that this strategy provides the possibility of applying
ECL imaging for cellular single-molecule analysis and cancer therapy.